Navigation Links
Ingredients in Red Yeast Rice Supplements Vary Widely: Study
Date:10/26/2010

TUESDAY, Oct. 26 (HealthDay News) -- There are widely inconsistent amounts of active ingredient in different formulations of popular red yeast rice supplements, a new study finds. The supplements are marketed as a way to lower cholesterol levels.

In addition, four of the 12 products included in the study had detectable levels of a potentially toxic compound called citrinin, which can damage the kidneys. The toxin is produced by a fungus.

In 2008, Americans spent about $20 million on red yeast rice supplements.

"Several studies have shown that specific formulations of red yeast rice reduce low-density lipoprotein [LDL or 'bad'] cholesterol significantly compared with placebo. This is likely related to the effects of monacolin K and the 13 other monacolins in the supplement, which also works to lower the production of cholesterol in the liver," wrote a team led by Dr. Ram Y. Gordon of Chestnut Hill Hospital in Philadelphia, and Abington Memorial Hospital in Abington, Pa.

In fact, monacolin K is purified and marketed as the cholesterol-lowering drug lovastatin (Mevacor), the researchers noted.

However, according to the study authors, in order to avoid being considered an unapproved drug, manufacturers do not standardize or reveal the levels of monacolin K or other monacolins in their red yeast rice supplements.

Analyses of the 12 products included in this study found that levels of total monacolins ranged from 0.31 milligrams to 11.15 milligrams per capsule, and levels of monacolin K or lovastatin ranged from 0.10 milligrams to just over 10 milligrams per capsule.

"Red yeast rice has been used for centuries for its medicinal properties and is an increasingly popular alternative lipid-lowering therapy that may benefit patients with a history of coronary disease who cannot take statins, subjects who refuse statins or who prefer a 'natural' approach to pharmacotherapy, or patients with a history of statin-associated myalgias [muscle pains]," the researchers wrote.

"However, our study found dramatic variability of monacolin levels in commercial products and the presence of citrinin in one-third of formulations," they added. "Further oversight and standardization of the production and labeling of red yeast rice products may address some of the concerns raised in this study. Until these issues are addressed, physicians should be cautious in recommending red yeast rice to their patients for the treatment of hyperlipidemia [high cholesterol] and primary and secondary prevention of cardiovascular disease."

The study appears in the Oct. 25 issue of the journal Archives of Internal Medicine.

More information

The American Heart Association has more about cholesterol.

-- Robert Preidt

SOURCE: JAMA/Archives news release, Oct. 25, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Shop like Celebrity Chefs at Downtown Santa Monica Farmers' Market. Easy Summer Recipes Incorporate Fresh Ingredients from the Farmers' Market
2. FDA Found Bacteria in Ingredients for Recalled Tylenol, Benadryl
3. Scientific exchange program promotes collaborative quality standards for drugs, food ingredients
4. Best Selling, Non Toxic Skin Brightener Does the Job Using Safe, Healthy Ingredients and Introduces New Anti Aging Ingredients
5. Latest quality and purity specifications for food ingredients help protect consumers
6. Unstable chromosome regions are the origin of yeasts brewing capacity
7. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
8. No Heart Benefit Seen From Folic Acid Supplements
9. Calcium Supplements Linked to Boost in Heart Attack Risk
10. How safe and effective are herbal dietary supplements?
11. New research finds no evidence that popular slimming supplements facilitate weight loss
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ingredients in Red Yeast Rice Supplements Vary Widely: Study
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... 05, 2016 , ... Pivot Point Consulting, a leading national ... & Services for HIT Implementation Support & Staffing report with an outstanding score ... by healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Colorize ... from on one drop zone to the next using Colorize's dynamic moving camera. Colorize ... project. This package includes a 3D slideshow environment with 1 to 5 focus points ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology: